NF-κB2 (p100) limits TNF-α-induced osteoclastogenesis

Journal of Clinical Investigation

Volumn 119, Issue 10, 2009, Pages 2879-2881

  Tanaka, Sakae ^a   Nakano, Hiroyasu ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR ALPHA;

HOMEOSTASIS; NONHUMAN; NOTE; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; MICE; MICE, KNOCKOUT; NF-KAPPA B P52 SUBUNIT; OSTEOCLASTS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349656597     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI40629     Document Type: Note

References (18)

1. Tanaka, S., Nakamura, K., Takahasi, N., and Suda, T. 2005. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol. Rev. 208:30-49. (Pubitemid 41746383)
2. Theill, L.E., Boyle, W.J., and Penninger, J.M. 2002. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20:795-823.
3. Scott, D.L., and Kingsley, G.H. 2006. Tumor necrosis factor inhibitors for rheumatoid arthritis. N. Engl. J. Med. 355:704-712. (Pubitemid 44244541)
4. Azuma, Y., Kaji, K., Katogi, R., Takeshita, S., and Kudo, A. 2000. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275:4858-4864. (Pubitemid 30108878)
5. Kim, N., et al. 2005. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 202:589-595. (Pubitemid 41248411)
6. Kobayashi, K., et al. 2000. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191:275-286. (Pubitemid 30060917)
7. Li, J., et al. 2000. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. U. S. A. 97:1566-1571. (Pubitemid 30118482)
8. Bonizzi, G., and Karin, M. 2004. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280-288. (Pubitemid 38610351)
9. Franzoso, G., et al. 1997. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 11:3482-3496. (Pubitemid 28023969)
10. Iotsova, V., et al. 1997. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3:1285-1289. (Pubitemid 27508833)
11. Novack, D.V., et al. 2003. The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis. J. Exp. Med. 198:771-781.
12. Vaira, S., et al. 2008. RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc. Natl. Acad. Sci. U. S. A. 105:3897-3902. (Pubitemid 351723496)
13. Yao, Z., Xing, L., and Boyce, B.F. 2009. NF-kB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism. J. Clin. Invest. 119:3024-3034.
14. He, J.Q., et al. 2006. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency. J. Exp. Med. 203:2413-2418.
15. Liao, G., Zhang, M., Harhaj, E.W., and Sun, S.C. 2004. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279:26243-26250. (Pubitemid 38798772)
16. Skaug, B., Jiang, X., and Chen, Z.J. 2009. The role of ubiquitin in NF-kappaB regulatory pathways. Annu. Rev. Biochem. 78:769-796.
17. Dejardin, E., et al. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity. 17:525-535. (Pubitemid 35223540)
18. Basak, S., et al. 2007. A fourth IkappaB protein within the NF-kappaB signaling module. Cell. 128:369-381. (Pubitemid 46123518)